Oncology

Oncology studies dominate the clinical trial landscape; and for the millions of patients each year facing a cancer diagnosis, the search for answers is unbearable. While advancements in oncology clinical research bring hope to patients, they present many challenges to drug developers, including:

• Complexity of innovative trial designs
• Enrollment challenges that hinder diversity and inclusion goals
• Intense competition for qualified sites and patients
• Higher data volume and collection requirements compared to trials in other therapeutic areas
• Changing standards of care and clinical strategies

To navigate these complexities, you need a clinical development partner and an experienced contract research organization. DP Clinical Project Managers and clinical teams have extensive experience in oncology clinical trial execution. We have performed Phase II-III oncology studies ranging in size from 1-40 sites and 15-500 patients and know how to successfully enroll and retain this oftentimes difficult patient population.